Month: September 2020

One company’s challenge is another company’s opportunity. Integra LifeSciences is hoping to offload its extremity orthopedic business to Smith & Nephew for $240 million in cash. The sale is expected to close around the end of the year and includes Integra’s upper and lower extremity orthopedics product portfolio, including ankle and shoulder arthroplasty, and hand and wrist
0 Comments
Some may ask the question, “What does a care coordinator do for my personal well-being?” There is no short answer as to what a patient can benefit from by receiving assistance from a care coordinator. Their job is to connect with high-risk individuals to uncover and identify needs in a patient-centered manner and in a
0 Comments
Video highlights of COVID-19 data trends as of September 29, 2020. This daily report shares critical data on the spread of COVID-19 over the last 24 hours. For the latest news, trends, and expert insights on the coronavirus pandemic, visit the JHU Coronavirus Resource Center: https://coronavirus.jhu.edu/ Explore COVID-19 trends around the world with our in-depth
0 Comments
Sep 30 2020 FUJIFILM Irvine Scientific, Inc., today announced that it has become the exclusive, worldwide distributor of cellnest®, a recombinant peptide attachment substrate that provides optimal adhesion and proliferation of stem cells in chemically defined, animal component-free conditions. Cellnest was designed and manufactured by FUJIFILM Corporation, joining its vast portfolio of solutions that support
0 Comments
With evolving news headlines about COVID-19, the mention of supply-chain shortages in the medical industry brings to mind surgical masks, protective equipment, and virus test kits. Yet since this time last year, there also have been headlines about supply-chain risks of another kind—those related to temporary or permanent closures of ethylene oxide (EtO) sterilization facilities. Several
0 Comments
Reviewed by Emily Henderson, B.Sc.Sep 29 2020 Diet remains an important part of disease prevention and management, and a new study suggests that consumption of fructose may worsen intestinal inflammation common to inflammatory bowel diseases (IBD). Led by David Montrose, PhD, of the Renaissance School of Medicine at Stony Brook University, the study is currently
0 Comments
Illumina and Grail Want to Reunite The rumors are indeed true – Illumina is attempting to acquire early cancer detection specialist Grail for about $8 billion. Grail was spun off from Illumina in 2016. The proposed acquisition comes hot on the heels of Grail announcing it was seeking to go public. EU Investigation into Google’s Fitbit Deal An
0 Comments
Video highlights of COVID-19 data trends as of September 28, 2020. This daily report shares critical data on the spread of COVID-19 over the last 24 hours. For the latest news, trends, and expert insights on the coronavirus pandemic, visit the JHU Coronavirus Resource Center: https://coronavirus.jhu.edu/ Explore COVID-19 trends around the world with our in-depth
0 Comments
Abbott Laboratories has scored a CE mark for the Freestyle Libre 3. The approval in Europe comes a few months after the Abbott Park, Il-based company won a nod from FDA for a second-generation version of the continuous glucose monitoring (CGM) technology. The FreeStyle Libre 3 technology provides continuous, real-time glucose readings automatically delivered to
0 Comments
Reviewed by Emily Henderson, B.Sc.Sep 28 2020 Because gastrointestinal stromal tumors (GIST) are sensitive to the targeted small molecule therapy imatinib, oncologists tend to treat all patients with metastatic GIST with this drug. However, because this rare type of cancer is caused by different genetic mutations, imatinib does not help all patients equally. To determine
0 Comments